Study Stopped
COVID 19
Exploring Breathing Patterns
EPISODE
Exploring Patterns of Speech and Breathing to Indicate the Presence of Obstructive Disease
1 other identifier
observational
100
1 country
1
Brief Summary
Study Title Exploring patterns of speech and breathing to indicate the presence of obstructive respiratory disease. Study Design Prospective Case Control Study Study Participants Participants will be patients attending the respiratory physiology clinic at the Cardiopulmonary Unit, Prince Charles Hospital for an assessment of their lung function. In addition a cohort of control participants without obstructive respiratory disease will be recruited with the assistance of the British Lung Foundation charity. Planned Size of Sample (if applicable) We have received funding for 52 ½ day sessions and we plan to recruit on average 2 participants per session. As such we aim to recruit a minimum of 100 participants. In addition we are working with the British Lung Foundation to recruit a smaller Cohort of control participants and aim to recruit a minimum of 25 control participants. Planned Study Period Jan 2019 - Aug 2019 Research Aim(s) This primary objective of this novel study it to create an anonymised database of speech patterns of patients with chronic respiratory disease and healthy aged matched controls for comparison with lung function and medical history. The primary aims are to:
- Collect breathing patterns from individuals under a range of talking modalities
- Understand how easy it is to gather short speech recordings
- Explore the preferences of patients to be recorded talking
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2019
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2019
CompletedFirst Submitted
Initial submission to the registry
February 10, 2021
CompletedFirst Posted
Study publicly available on registry
February 15, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2022
CompletedFebruary 15, 2021
February 1, 2021
3 years
February 10, 2021
February 10, 2021
Conditions
Outcome Measures
Primary Outcomes (3)
Collect breathing patterns from individuals under a range of talking modalities
breathing pattern
less than 5 minutes
Understand how easy it is to gather short speech recordings
verbal description
3 minutes
Explore the preferences of patients to be recorded talking
verbal description
3 minutes
Interventions
Speech Recognition
Eligibility Criteria
Adult patient \>18 years old referred for spirometry in the Respiratory Physiology Clinic at Prince Charles Hospital; Eligibility Criteria - Control Participants Control participants will be contact through the British Lung Foundations local groups who have indicated their willingness to be involved in local clinical research to act as control participants. As all prospective participants will have had their respiratory function measured before taking part by a Respiratory Physiologist, we do not expect to have to screen for medical issues for participation in the study. Furthermore, the actual tests the participants will be undertaking will be non - invasive, submaximal and will require little or no effort.
You may qualify if:
- Adult patient \>18 years old referred for spirometry in the Respiratory Physiology Clinic at Prince Charles Hospital;
- Clinically defined obstructive or restrictive respiratory disease (indicated by spirometry)
- Clinically stable (indicated by being able to undergo spirometry)
- No significant unstable disease co-morbidities (indicated by being able to undergo spirometry)
- Capable of providing informed consent.
- Willing to take part in all study measurements.
- The speaking exercise will be conducted in English on this study.
- \. No obstructive or restrictive respiratory disease (indicated by spirometry) 2. Clinically stable (indicated by being able to undergo spirometry) 3. No significant unstable disease co-morbidity's (indicated by being able to undergo spirometry) 4. Capable of providing informed consent. 5. Willing to take part in all study measurements. 6. The speaking exercise will be conducted in English on this study. 7. Participants are not taking part in any other research.
You may not qualify if:
- Any form of challenge testing in the Respiratory Physiology Department involving salbutamol.
- Severe Sensory and/or Cognitive Impairment
- Inability to complete study measurements
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cwm Taf Morgannwg Health Board
Abercynon, Wales, CF45 4SN, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 10, 2021
First Posted
February 15, 2021
Study Start
March 1, 2019
Primary Completion
March 1, 2022
Study Completion
March 1, 2022
Last Updated
February 15, 2021
Record last verified: 2021-02
Data Sharing
- IPD Sharing
- Will not share